Clinical Trials Logo

Clinical Trial Summary

The study focuses on the analysis of enamel defects grouping together hypomineralization and hypoplasia. It focuses on 3 very characteristic enamel pathologies that are most often encountered in dental consultations: Molar Incisor Hypomineralization (MIH), dental fluorosis (FD) and amelogenesis imperfecta (AI). The research focuses on the use of a spectrophotometer for measuring tooth colors: the Zfx SpectroShade® (MHT) and its software as a means of early diagnosis of pre-eruptive enamel abnormalities. The main objective of the study is to analyze the color parameters of teeth affected with one of the 3 enamel abnormalities for use of the spectrophotometer as a non-invasive diagnostic tool for enamel defects. The secondary objective is focused on the biological, structural and physicochemical characterizations of these different enamel pathologies from extracted teeth or enamel biopsies that must be ground to achieve a restoration.


Clinical Trial Description

Methodology: V1 inclusion visit (D1): The subjects will be screened during a consultation carried out as part of the treatment in the participating dentistry departments. The inclusion and non-inclusion criteria for participants will be verified and the study will be offered to eligible patients and controls. The research briefing note will be given and the non-objection of the participants (adults and representative (s) of parental authority) will be collected. The investigator will then take the photographs and spectrophotometer shots (at least 2 teeth per participant). V2 follow-up visit (within 2 months of the inclusion visit (D2 to M2)): The patients will be reviewed in consultation as part of the treatment for selective grinding for dental restoration or extraction (if the tooth (s) is (are) no longer storable). The teeth or pathological enamel samples will be recovered and centralized at the Laboratory of Oral Molecular Physiopathology. Biological, structural and physico-chemical analyzes will be carried out from these samples. In order to ensure follow-up of participants, the principal investigator of each center will maintain a correspondence table including the participant's identity and his research identification number. He will also keep a register of oppositions up to date. The subject's opposition or participation will be notified in his medical file. A copy of the briefing notes and non-objection forms signed by the dentist will be kept on site with the research documents. Minors who become adults during their participation will benefit from appropriate information and their non-objection will be collected. Primary endpoint Analysis, using the spectrophotometer, of the numerical values of the color of the teeth in each of the populations studied (Hereditary amelogenesis imperfecta (AIH), dental fluorosis (FD), Hypomineralization Incisors and Molar (MIH) and control). For each pathology, the values of these parameters will be compared. Secondary endpoints - Intra-pathology classification according to the severity of each pathology. - Characterization and biological, structural and physicochemical analysis of these different pathologies from extracted teeth or enamel biopsy to be ground to achieve a restoration. Sample analysis The teeth samples will be stored at room temperature in the Oral Molecular Physiopathology laboratory in the Research Center. During the research, biological, structural and physicochemical analyzes will be carried out at the laboratory or in another laboratory in France or abroad. A contract will be established upstream of these analyzes with the partner laboratory. At the end of the research, samples not destroyed by destructive analysis techniques will be embedded in the resin and stored for 10 years before being destroyed. These samples can be used for additional analyzes (biological, structural and physico-chemical) according to the request of the references for the publication process. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04704089
Study type Observational
Source Assistance Publique - Hôpitaux de Paris
Contact Sophia HOUARI, MCU-PH
Phone 06 12 16 88 35
Email sophia.houari@aphp.fr
Status Recruiting
Phase
Start date July 18, 2022
Completion date September 18, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT04927962 - Psycho-social Impact of Amelogenesis and Dentinogenesis Imperfecta
Active, not recruiting NCT04897724 - Clinical Performance of Composites in Patients With Amelogenesis Imperfecta N/A
Active, not recruiting NCT03810859 - Non-syndromic Inherited Anomalies of Mineralized Tooth Tissues: a Whole Exome Study to Identify New Pathogenic Variants N/A
Terminated NCT01746121 - Amelogenesis Imperfecta
Recruiting NCT05343247 - Dental Age Estimation by Different Methods in Patients With Amelogenesis Imperfecta
Not yet recruiting NCT02994862 - E. Max Laminate Veneers With and Without Using Galla Chinnesis as Natural Cross Linking and Remineralizing Agent N/A